Mechanisms of Heart Failure: Developments in Cardiovascular Medicine, cartea 167
Editat de Pawan K. Singal, Ian M.C. Dixon, Robert E. Beamish, Naranjan S. Dhallaen Limba Engleză Paperback – 12 oct 2012
Din seria Developments in Cardiovascular Medicine
- 5%
Preț: 1044.79 lei - 5%
Preț: 380.99 lei - 5%
Preț: 375.50 lei - 5%
Preț: 1047.77 lei - 5%
Preț: 1048.21 lei - 5%
Preț: 1047.77 lei - 5%
Preț: 643.30 lei - 5%
Preț: 630.82 lei - 5%
Preț: 628.80 lei - 5%
Preț: 637.41 lei - 5%
Preț: 636.74 lei - 5%
Preț: 641.94 lei - 5%
Preț: 405.96 lei - 5%
Preț: 383.16 lei - 5%
Preț: 1363.81 lei - 5%
Preț: 362.13 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 1382.39 lei - 5%
Preț: 362.47 lei - 5%
Preț: 354.38 lei - 5%
Preț: 365.81 lei - 5%
Preț: 2034.92 lei - 5%
Preț: 353.34 lei - 5%
Preț: 352.64 lei - 5%
Preț: 357.02 lei - 5%
Preț: 356.87 lei - 5%
Preț: 752.94 lei - 5%
Preț: 685.66 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 361.23 lei - 5%
Preț: 359.30 lei - 5%
Preț: 695.99 lei - 5%
Preț: 1061.25 lei - 5%
Preț: 2034.57 lei - 5%
Preț: 688.44 lei - 5%
Preț: 357.91 lei - 5%
Preț: 694.44 lei - 5%
Preț: 634.66 lei - 5%
Preț: 361.08 lei - 5%
Preț: 1367.84 lei - 5%
Preț: 687.74 lei - 5%
Preț: 760.14 lei
Preț: 1364.67 lei
Preț vechi: 1436.50 lei
-5% Nou
Puncte Express: 2047
Preț estimativ în valută:
241.49€ • 283.17$ • 212.07£
241.49€ • 283.17$ • 212.07£
Carte tipărită la comandă
Livrare economică 31 ianuarie-14 februarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461358275
ISBN-10: 1461358272
Pagini: 484
Ilustrații: XXV, 453 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
ISBN-10: 1461358272
Pagini: 484
Ilustrații: XXV, 453 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.67 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I. Subcellular Basis of Heart Failure.- 1. Tumor Necrosis Factor-Alpha in Chronic Heart Failure.- 2. Myocardial Ribonuclease Activity in Heart Failure.- 3. ?-Adrenergic Receptor Mechanisms in Heart Failure.- 4. Vascular ?-Adrenergic Function in Congestive heart Failure.- 5. Altered Myocardial Neurotransmitter and 1,2-Diacylglycerol Concentrations in Right Ventricular Hypertrophy and Failure in Rats.- 6. Metabolic Changes in Nonischemic Myocardium During Pump Failure.- 7. Cardiac Extracellular Matrix and its Role in the Development of Heart Failure.- 8. SHHF/Mcc-fa3cp— Rat Model: A Genetic Model of Congestive Heart Failure.- 9. Left Ventricular Mass and Diastolic Function in Young Individuals with a first elevated “Casual” Blood Pressure.- 10. Factors Responsible for Left Ventricular Underfilling in Pure Mitral Stenosis.- 11. Improved Preservation of Myocardial ultrastructure in Perfusion-Fixed Human Heart Expiants.- 12. Involvement of Leukotoxin in the Pathogenesis of Patients with Extensive Burns.- 13. Differential Regulation of Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase Isozymes.- II. Pathophysiologic Aspects of Cardiomyopathies.- 14. Adriamycin Cardiomyopathy and its Prevention in an Animal Model.- 15. Alterations in Sarcolemmal Phospholipid Base Exchange Enzymatic Activities in Diabetic Cardiomyopathy.- 16. Myocardial Lipid Peroxidation and Diabetes.- 17. Molecular Biologic Changes of Adenine Nucleotide Translocator in J-2-N Cardiomyopathic Hamsters.- 18. Renin-Angiotensin System and the Congenital Cardiomyopathic Hamster.- 19. Dietary Mercury Induces Congestive Cardiomyopathy in the Arctic.- 20. Peripheral Resistance to Atrial Natriuretic Peptide in Patients with Idiopathic Dilated.- 21. Effect of Ethanol on Allylamine-Induced SubendocardialFibrosis.- 22. Nitric Oxide: Friend and Foe in Myocardial Ischemia and Reperfusion.- 23. Role of Leukocytes and Subcellular Abnormalities in Diastolic Dysfunction During Ischemia-Reperfusion.- 24. Calcium Channel Blockade Ameliorates Cardiac Dysfunction and Failure in Ischemic Cardiomyopathy.- 25. Alterations in Autonomic Nervous System and Heart Mitochondrial Function in Rats Treated with Cyclophosphamide.- III. Treatment of Heart Failure.- 26. Combined Aerobic and Strength Training in Congestive Heart Failure Patients: Pilot Project on Safety and Feasibility.- 27. Factors Relating to 6 Minute Walk Performance in Heart Failure Patients.- 28. Dynamic Cardiomyoplasty: Management of Heart Failure Using Autologous Skeletal Muscle.- 29. Cardiac Cell Transplantation.- 30. Effects of Catalase on Volume-Overload Heart Failure.- 31. Major Determinants of Survival and Nonsurvival of Intra-aortic balloon Pumping.- 32. End-Stage Ischemic Heart Disease: Effects of Complete Myocardial Revascularization and Left Ventricular Patch Repair Following Scar Resection 369.- 33. Acute Enoximone Effect on Systemic Hemodynamics, Renal Function, and Hormonal Activation in Patients with Heart Failure.- 34. Angiotensin II Receptor Antagonist, E-4177, Inhibits Progression of Reactive Cardiac Hypertrophy Associated with Myocardial Infarction in Rats.- 35. Effects of Catecholamine and Amrinone on the Metabolism of Noninfarcted Myocardium in Cardiogenic Shock.- 36. Effects of Angiotensin Converting Enzyme Inhibitors on Acute Heart Failure Induced in the Anesthetized Dog with Microsphere Injection.- 37. Recruitment of Ventricular Function with Adjunctive Nitrate Therapy After Late Reperfusion.- 38. Neuromuscular Assessment of Heart Failure Patients.